Email Updates

Search form

You are here

CONRAD 118

Status
Completed
Phase
I
Principal Investigator(s)
Jill Schwartz
Objective

To evaluate the interaction of TFV gel, antifungal cream, antimicrobial gel and a contraceptive ring.

Prevention Option(s)
Hormonal Contraceptives and HIV
Microbicides
Study Design
Randomized
Open label
Arms and Assigned Interventions
Description
Tenofovir gel only
Mode of Delivery
Gel
Products
1% tenofovir gel
ARMs
Experimental
Description
Vaginal products & tenofovir gel: tenofovir gel, antifungal cream, antimicrobial gel, contraceptive ring
Mode of Delivery
Gel
Ring
Products
1% tenofovir gel
Contraceptive Vaginal Ring
Metronidazole
Terconazole
ARMs
Experimental
Description
Vaginal products only: antifungal cream, antimicrobial gel, aontraceptive ring
Mode of Delivery
Gel
Ring
Products
Contraceptive Vaginal Ring
Metronidazole
Terconazole
ARMs
Experimental
Trial Sponsors
CONRAD
December 2013
December 2014
Enrollment
54
18
Years
50
Years
Population
Women
Sites

Bronx-Lebanon Hospital

New York, New York
United States of America

University of California

San Francisco, California
United States of America